Brown & Brown (NYSE: BRO ) is an insurance broker I've covered twice and previously rated a Hold. Both times I felt it was a solid company but already priced for all of its growth.I analyze securities based on value investing, an owner's mindset, and a long-term horizon. I don't write sell articles as those are considered short theses, and I never recommend shorting.Former advisory representative at Fidelity. I do my own investing now and share my research here.Analyst’s Disclosure:I/we have no stock, optio ...

Core Viewpoint - Brown & Brown (NYSE: BRO) is recognized as a solid insurance broker, but its stock is perceived to be fully priced for growth, leading to a previous rating of Hold [1]. Company Analysis - The analysis is based on value investing principles, emphasizing an owner's mindset and a long-term investment horizon [1]. - The author does not engage in short selling or provide sell recommendations, indicating a focus on long-term value rather than short-term market fluctuations [1]. Analyst's Position - The analyst has no current stock or derivative positions in Brown & Brown or any mentioned companies, nor plans to initiate any within the next 72 hours [2]. - The article reflects the analyst's personal opinions and is not influenced by compensation from any company mentioned [2].

Core Points - Faruqi & Faruqi, LLP is investigating potential claims against SelectQuote, Inc. and reminds investors of the October 10, 2025 deadline to seek the role of lead plaintiff in a federal securities class action [2][3] Allegations Against SelectQuote - The complaint alleges that SelectQuote and its executives violated federal securities laws by making false and misleading statements, including directing Medicare beneficiaries to plans that compensated SelectQuote the most, rather than providing unbiased comparisons [4] - SelectQuote is accused of receiving illegal kickbacks from health insurance companies to steer Medicare beneficiaries towards certain plans, which led to non-compliance with applicable laws and regulations [4][5] - The U.S. Department of Justice filed a complaint against SelectQuote, alleging that from 2016 to at least 2021, the company received tens of millions of dollars in illegal kickbacks and engaged in discriminatory practices against less profitable beneficiaries [5] Stock Market Reaction - Following the DOJ's allegations, SelectQuote's stock price fell by $0.61, or 19.2%, closing at $2.56 per share on May 1, 2025, with unusually heavy trading volume [5]

BEIJING, Oct. 10, 2025 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd. (Nasdaq: TIRX) (the “Company”), today announced that it has entered into a securities purchase agreement with certain institutional investors for the purchase and sale of 2,000,000 Class A ordinary shares and warrants to purchase up to an aggregate of additional 4,000,000 Class A ordinary shares in a registered direct offering (the "Offering") at a combined purchase price of $1.50 per share and accompanying warrants, resulting in gross p ...

Core Points - Arthur J. Gallagher & Co. will release its third quarter 2025 earnings after the market closes on October 30, 2025 [1] - J. Patrick Gallagher, Jr., Chairman and CEO, will host a conference call on the same day at 5:30 pm ET/4:30 pm CT [1] - The conference call will be broadcast live on Gallagher's website, with a replay available approximately two hours after the broadcast [2] Company Overview - Arthur J. Gallagher & Co. is a global insurance brokerage, risk management, and consulting services firm [2] - The company is headquartered in Rolling Meadows, Illinois, and operates in approximately 130 countries worldwide [2]

Arthur J. Gallagher & Co. (NYSE: AJG ) is a global specialty insurance broker. With uncertainty about tariffs, interest rates, inflation, and many other macroeconomic stressors, many investors look to insurance, and brokers provide the profits without the underwriting risks.I analyze securities based on value investing, an owner's mindset, and a long-term horizon. I don't write sell articles as those are considered short theses, and I never recommend shorting.Former advisory representative at Fidelity. I do ...

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action lawsuit on behalf of purchasers and acquirers of SelectQuote, Inc. (NYSE: SLQT) securities between September 9, 2020 and May 1, 2025, both dates inclusive (the "Class Period†). SelectQuote is an insurance broker. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Alleg. ...

Core Insights - ClearBridge Investments released its third-quarter 2025 investor letter for the ClearBridge Dividend Strategy, highlighting strong stock market performance and gains from AI exposure, despite lagging behind the S&P 500 Index benchmark [1] Group 1: Company Performance - The third-quarter performance of ClearBridge Dividend Strategy was strong, although it underperformed the S&P 500 Index [1] - Marsh & McLennan Companies, Inc. (NYSE:MMC) had a one-month return of 2.55% but lost 10.11% over the last 52 weeks, closing at $203.84 per share with a market capitalization of $100.213 billion on October 7, 2025 [2] - ClearBridge initiated new positions in Marsh & McLennan and Old Dominion Freight Line, citing Marsh & McLennan as a high-quality compounder that is currently undervalued due to temporary pricing softness in the industry [3] Group 2: Investment Sentiment - Marsh & McLennan is not among the 30 most popular stocks among hedge funds, with 60 hedge fund portfolios holding the stock at the end of Q2 2025, an increase from 56 in the previous quarter [3] - While acknowledging Marsh & McLennan's potential, ClearBridge believes certain AI stocks present greater upside potential and lower downside risk [3]

Core Viewpoint - A class action lawsuit has been filed against SelectQuote, Inc. for allegedly violating the False Claims Act by directing Medicare beneficiaries to insurers that compensated the company the most, rather than providing unbiased comparisons of insurance plans [2][3]. Group 1: Allegations Against SelectQuote - The complaint alleges that SelectQuote failed to disclose that it directed Medicare beneficiaries to plans based on compensation rather than quality [2]. - It is claimed that SelectQuote did not provide unbiased comparison shopping for Medicare Advantage plans and received illegal kickbacks from insurers [2]. - The U.S. Department of Justice filed a complaint stating that SelectQuote received "tens of millions of dollars" in illegal kickbacks from 2016 to at least 2021 [3]. Group 2: Impact on Stock Price - Following the DOJ's allegations, SelectQuote's stock price fell by $0.61, or 19.2%, closing at $2.56 per share on May 1, 2025 [3]. Group 3: Class Action Participation - Shareholders interested in participating as lead plaintiffs in the class action must file their papers by October 10, 2025 [4]. - Shareholders can remain absent class members and still be eligible for recovery without participating in the case [4]. Group 4: Company Background - Robbins LLP is a law firm recognized for its work in shareholder rights litigation, helping shareholders recover losses and improve corporate governance since 2002 [5].

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In SelectQuote (SLQT) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in SelectQuote between September 9, 2020 and May 1, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) -- What’s Happe ...